{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:50:26Z","timestamp":1790740226593,"version":"4.1.0"},"reference-count":101,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["RRCT"],"published-print":{"date-parts":[[2019,5,31]]},"abstract":"<jats:sec><jats:title>Introduction:<\/jats:title><jats:p>Historically, spontaneous bacterial peritonitis (SBP) has represented one of the most frequent and relevant infectious complications of advanced liver disease, and this is still valid today. Nevertheless, in recent years the role of fungi as causative pathogens of primary peritonitis in patients with cirrhosis has become not negligible. Another issue is linked with the traditional distinction, instrumental in therapeutic choice, between community-acquired and nosocomial forms, according to the onset. Between these two categories, another one has been introduced: the so-called \u201chealthcare-associated infections\u201d.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>To discuss the most controversial aspects in the management of SBP nowadays in the light of best available evidence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>A review of recent literature through MEDLINE was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>The difference between community-acquired and nosocomial infections is crucial to guide empiric antibiotic therapy, since the site of acquisition impact on the likelihood of multidrug-resistant bacteria as causative agents. Therefore, third-generation cephalosporins cannot be considered the mainstay of treatment in each episode. Furthermore, the distinction between healthcare-associated and nosocomial form seems very subtle, especially in areas wherein antimicrobial resistance is widespread, warranting broad-spectrum antibiotic regimens for both. Finally, spontaneous fungal peritonitis is a not common but actually underestimated entity, linked to high mortality. Especially in patients with septic shock and\/or failure of an aggressive antibiotic regimen, the empiric addition of an antifungal agent might be considered.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Spontaneous bacterial peritonitis is one of the most important complications in patients with cirrhosis. A proper empiric therapy is crucial to have a positive outcome. In this respect, a careful assessment of risk factors for multidrug-resistant pathogens is crucial. Likewise important, mostly in nosocomial cases, is not to overlook the probability of a fungal ascitic infection, namely a spontaneous fungal peritonitis.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1574887114666181204102516","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T12:09:55Z","timestamp":1543925395000},"page":"129-135","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Unsolved Issues in the Treatment of Spontaneous Peritonitis in Patients with Cirrhosis: Nosocomial Versus Community-acquired Infections and the Role of Fungi"],"prefix":"10.2174","volume":"14","author":[{"given":"Alberto Enrico","family":"Maraolo","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples Federico II, 80131, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Riccardo","family":"Buonomo","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples Federico II, 80131, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Zappulo","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples Federico II, 80131, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Scotto","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples Federico II, 80131, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio","family":"Pinchera","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples Federico II, 80131, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Gentile","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples Federico II, 80131, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","volume":"383","author":"Tsochatzis E.A.","year":"2014","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis.","journal-title":"Lancet"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.dld.2004.07.013","volume":"36","author":"Stroffolini T.","year":"2004","unstructured":"Stroffolini T, Sagnelli E, Mele A, Crax\u00ec A, Almasio P. The aetiology of chronic hepatitis in Italy: Results from a multicentre national study.","journal-title":"Dig Liver Dis"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12916-017-0966-6","volume":"15","author":"Berzigotti A.","year":"2017","unstructured":"Berzigotti A. Advances and challenges in cirrhosis and portal hypertension.","journal-title":"BMC Med"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1517\/13543784.2015.1059820","volume":"24","author":"Gentile I.","year":"2015","unstructured":"Gentile I, Zappulo E, Buonomo AR, Maraolo AE, Borgia G. Beclabuvir for the treatment of hepatitis C.","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2174\/1574887111666151217123222","volume":"11","author":"Morisco F.","year":"2016","unstructured":"Morisco F, Masarone M, Rosato V. Impact of Telaprevir in HCV Patients with Cirrhosis and RVR: Real-Life data from boceprevir or telaprevir based \u201cTriple Therapy\u201d experience in Southern Italy.","journal-title":"Rev Recent Clin Trials"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/157488709789957628","volume":"4","author":"Enomoto M.","year":"2009","unstructured":"Enomoto M, Tamori A, Kawada N. Emerging antiviral drugs for hepatitis C virus.","journal-title":"Rev Recent Clin Trials"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00592-007-0259-1","volume":"44","author":"Tosone G.","year":"2007","unstructured":"Tosone G, Borgia G, Gentile I. A case of pegylated interferon alpha-related diabetic ketoacidosis: can this complication be avoided?","journal-title":"Acta Diabetol"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/jir.2005.25.283","volume":"25","author":"Gentile I.","year":"2005","unstructured":"Gentile I, Viola C, Reynaud L. Hemolytic anemia during pegylated IFN-alpha2b plus ribavirin treatment for chronic hepatitis C: Ribavirin is not always the culprit.","journal-title":"J Interferon Cytokine Res"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1574887108666131213120354","volume":"9","author":"Gentile I.","year":"2014","unstructured":"Gentile I, Borgia F, Zappulo E. Efficacy and safety of sofosbuvir in the treatment of chronic Hepatitis C: The dawn of a new era.","journal-title":"Rev Recent Clin Trials"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jhep.2009.12.023","volume":"52","author":"Gentile I.","year":"2010","unstructured":"Gentile I, Borgia G. Surrogate endpoints and non-inferiority trials in chronic viral hepatitis.","journal-title":"J Hepatol"},{"key":"ref=11","first-page":"289","volume":"3","author":"","year":"2018","unstructured":". The Lancet Gastroenterology Hepatology. Treatment of hepatitis C: momentum still needed.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1080\/17474124.2016.1234375","volume":"10","author":"Gentile I.","year":"2016","unstructured":"Gentile I, Maraolo AE, Niola M. Limiting the access to direct-acting antivirals against HCV: An ethical dilemma.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10096-015-2341-x","volume":"34","author":"Orlando R.","year":"2015","unstructured":"Orlando R, Foggia M, Maraolo AE. Prevention of hepatitis B virus infection: From the past to the future.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41395-018-0058-z","volume":"113","author":"Schmeltzer P.A.","year":"2018","unstructured":"Schmeltzer PA, Russo MW. Clinical narrative: Autoimmune hepatitis.","journal-title":"Am J Gastroenterol"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","volume":"24","author":"Leoni S.","year":"2018","unstructured":"Leoni S, Tovoli F, Napoli L. Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis.","journal-title":"World J Gastroenterol"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2174\/1574887111666160815102725","volume":"11","author":"Almeda-Valdes P.","year":"2016","unstructured":"Almeda-Valdes P, Altamirano-Barrera A, Uribe M, M\u00e9ndez-S\u00e1nchez N. Metabolic features of alcoholic liver disease.","journal-title":"Rev Recent Clin Trials"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41575-018-0045-2","volume":"15","author":"Bernardi M.","year":"2018","unstructured":"Bernardi M, Caraceni P. Novel perspectives in the management of decompensated cirrhosis.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"D\u2019Amico G.","year":"2006","unstructured":"D\u2019Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.","journal-title":"J Hepatol"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","volume":"38","author":"Moore K.P.","year":"2003","unstructured":"Moore KP, Wong F, Gines P. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.","journal-title":"Hepatology"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MCG.0b013e318157464b","volume":"43","author":"Gentile I.","year":"2009","unstructured":"Gentile I, Viola C, Graf M. A simple noninvasive score predicts gastroesophageal varices in patients with chronic viral hepatitis.","journal-title":"J Clin Gastroenterol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4254\/wjh.v9.i6.293","volume":"9","author":"Acevedo J.G.","year":"2017","unstructured":"Acevedo JG, Cramp ME. Hepatorenal syndrome: Update on diagnosis and therapy.","journal-title":"World J Hepatol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/ajg.2016.498","volume":"112","author":"Tripodi A.","year":"2017","unstructured":"Tripodi A, Primignani M, Mannucci PM, Caldwell SH. Changing concepts of cirrhotic coagulopathy.","journal-title":"Am J Gastroenterol"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.3748\/wjg.v20.i18.5442","volume":"20","author":"Nusrat S.","year":"2014","unstructured":"Nusrat S, Khan MS, Fazili J, Madhoun MF. Cirrhosis and its complications: Evidence based treatment.","journal-title":"World J Gastroenterol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","volume":"2","author":"Llovet J.M.","year":"2016","unstructured":"Llovet JM, Zucman-Rossi J, Pikarsky E. Hepatocellular carcinoma.","journal-title":"Nat Rev Dis Primers"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3748\/wjg.v24.i12.1285","volume":"24","author":"Soulaidopoulos S.","year":"2018","unstructured":"Soulaidopoulos S, Cholongitas E, Giannakoulas G, Vlachou M, Goulis I. Review article: Update on current and emergent data on hepatopulmonary syndrome.","journal-title":"World J Gastroenterol"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.ejim.2017.09.014","volume":"46","author":"Gentile I.","year":"2017","unstructured":"Gentile I, Buonomo AR, Scotto R, Zappulo E, Borgia G. Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stage.","journal-title":"Eur J Intern Med"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","volume":"139","author":"Arvaniti V.","year":"2010","unstructured":"Arvaniti V, D\u2019Amico G, Fede G. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.","journal-title":"Gastroenterology"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/ajg.2017.19","volume":"12","author":"Dionigi E.","year":"2017","unstructured":"Dionigi E, Garcovich M, Borzio M. Bacterial infections change natural history of cirrhosis irrespective of liver disease severity.","journal-title":"Am J Gastroenterol"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.gastro.2014.05.005","volume":"147","author":"Jalan R.","year":"2014","unstructured":"Jalan R, Yurdaydin C, Bajaj JS. World gastroenterology organization working party. Toward an improved definition of acute-on-chronic liver failure.","journal-title":"Gastroenterology"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","volume":"61","author":"Albillos A.","year":"2014","unstructured":"Albillos A, Lario M, \u00c1lvarez-Mon M. Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance.","journal-title":"J Hepatol"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","volume":"60","author":"Jalan R.","year":"2014","unstructured":"Jalan R, Fernandez J, Wiest R. Bacterial infections in cirrhosis: A position statement based on the EASL special conference 2013.","journal-title":"J Hepatol"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4254\/wjh.v7.i3.304","volume":"7","author":"Lutz P.","year":"2015","unstructured":"Lutz P, Nischalke HD, Strassburg CP, Spengler U. Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver.","journal-title":"World J Hepatol"},{"key":"ref=33","unstructured":"Bartoletti M, Giannella M, Lewis R, et al. A prospective multicenter study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients Clin Microbiol Infect 2017; 24(5): 546 e1-546 e8."},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","volume":"49","author":"Runyon B.A.","year":"2009","unstructured":"Runyon BA. Management of adult patients with ascites due to cirrhosis: an update.","journal-title":"Hepatology"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","volume":"53","author":"","year":"2010","unstructured":". EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.","journal-title":"J Hepatol"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"","year":"2018","unstructured":". EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.","journal-title":"J Hepatol"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/gutjnl-2011-300779","volume":"61","author":"Wiest R.","year":"2012","unstructured":"Wiest R, Krag A, Gerbes A. Spontaneous bacterial peritonitis: Recent guidelines and beyond.","journal-title":"Gut"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/apt.13135","volume":"41","author":"","year":"2015","unstructured":". Abraldes JG, Arabi YM, Kumar A. Appropriate and timely antimicrobial therapy in cirrhotic patients with spontaneous bacterial peritonitis-associated septic shock: A retrospective cohort study.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.3748\/wjg.v22.i34.7742","volume":"22","author":"Fiore M.","year":"2016","unstructured":"Fiore M, Leone S. Spontaneous fungal peritonitis: Epidemiology, current evidence and future prospective.","journal-title":"World J Gastroenterol"},{"key":"ref=40","first-page":"128","volume":"26","author":"Anastasiou J.","year":"2013","unstructured":"Anastasiou J, Williams R. When to use antibiotics in the cirrhotic patient? The evidence base.","journal-title":"Ann Gastroenterol"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2147\/TCRM.S144262","volume":"13","author":"Fiore M.","year":"2017","unstructured":"Fiore M, Maraolo AE, Leone S. Spontaneous peritonitis in critically ill cirrhotic patients: a diagnostic algorithm for clinicians and future perspectives.","journal-title":"Ther Clin Risk Manag"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/apt.13172","volume":"41","author":"Dever J.B.","year":"2015","unstructured":"Dever JB, Sheikh MY. Review article: Spontaneous bacterial peritonitis-bacteriology, diagnosis, treatment, risk factors and prevention.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.3748\/wjg.v22.i34.7742","volume":"22","author":"Fiore M.","year":"2016","unstructured":"Fiore M, Leone S. Spontaneous fungal peritonitis: Epidemiology, current evidence and future prospective.","journal-title":"World J Gastroenterol"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","volume":"49","author":"Runyon B.A.","year":"2009","unstructured":"Runyon BA. Management of adult patients with ascites due to cirrhosis: an update.","journal-title":"Hepatology"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.20632","volume":"41","author":"Wiest R.","year":"2005","unstructured":"Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis.","journal-title":"Hepatology"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.clineuro.2015.10.007","volume":"139","author":"Somma T.","year":"2015","unstructured":"Somma T, Maraolo AE, Esposito F. Efficacy of ultra-short single agent regimen antibiotic chemo-prophylaxis in reducing the risk of meningitis in patients undergoing endoscopic endonasal transsphenoidal surgery.","journal-title":"Clin Neurol Neurosurg"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMra1312885","volume":"371","author":"Musher D.M.","year":"2014","unstructured":"Musher DM, Thorner AR. Community-acquired pneumonia.","journal-title":"N Engl J Med"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cmi.2016.01.007","volume":"22","author":"Van De Beek D.","year":"2016","unstructured":"Van De Beek D, Cabellos C, Dzupova O. ESCMID guideline: Diagnosis and treatment of acute bacterial meningitis.","journal-title":"Clin Microbiol Infect"},{"key":"ref=49","first-page":"118","volume":"41","author":"Piccirilli G.","year":"2018","unstructured":"Piccirilli G, Chiereghin A, Gabrielli L. Infectious meningitis\/encephalitis: Evaluation of a rapid and fully automated multiplex PCR in the microbiological diagnostic workup.","journal-title":"New Microbiol"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/hep.1840050319","volume":"5","author":"Felisart J.","year":"1985","unstructured":"Felisart J, Rimola A, Arroyo V. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections.","journal-title":"Hepatology"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/hep.1840210312","volume":"21","author":"Rimola A.","year":"1995","unstructured":"Rimola A, Salmer\u00f3n JM, Clemente G. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomized, multicenter study.","journal-title":"Hepatology"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0016-5085(96)70069-0","volume":"111","author":"Navasa M.","year":"1996","unstructured":"Navasa M, Follo A, Llovet JM. Randomized, comparative study of oral ofloxacin intravenous cefotaxime in spontaneous bacterial peritonitis.","journal-title":"Gastroenterology"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","volume":"341","author":"Sort P.","year":"1999","unstructured":"Sort P, Navasa M, Arroyo V. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.","journal-title":"N Engl J Med"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0168-8278(00)80221-4","volume":"32","author":"Ricart E.","year":"2000","unstructured":"Ricart E, Soriano G, Novella MT. Amoxicillin-clavulanic acid cefotaxime in the therapy of bacterial infections in cirrhotic patients.","journal-title":"J Hepatol"},{"key":"ref=55","volume":"3","author":"Soares-Weiser K.","year":"2001","unstructured":"Soares-Weiser K, Brezis M, Leibovici L. Antibiotics for spontaneous bacterial peritonitis in cirrhotics.","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"Magiorakos A.P.","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.","journal-title":"Clin Microbiol Infect"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s12072-014-9522-z","volume":"8","author":"Botwin G.J.","year":"2014","unstructured":"Botwin GJ, Morgan TR. Bacterial infections in cirrhosis.","journal-title":"Hepatol Int"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/liv.13645","volume":"38","author":"Piano S.","year":"2018","unstructured":"Piano S, Brocca A, Mareso S, Angeli P. Infections complicating cirrhosis.","journal-title":"Liver Int"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.25532","volume":"55","author":"Fern\u00e1ndez J.","year":"2012","unstructured":"Fern\u00e1ndez J, Acevedo J, Castro M. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study.","journal-title":"Hepatology"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.cgh.2012.08.017","volume":"10","author":"Tandon P.","year":"2012","unstructured":"Tandon P, DeLisle A, Topal JE, Garcia-Tsao G. High prevalence of antibiotic- resistant bacterial infections among patients with cirrhosis at a US liver center.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1080\/14656566.2018.1505867","volume":"19","author":"Maraolo A.E.","year":"2018","unstructured":"Maraolo AE, Gentile I, Pinchera B, Nappa S, Borgia G. Current and emerging pharmacotherapy for the treatment of bacterial peritonitis.","journal-title":"Expert Opin Pharmacother"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0168-8278(12)60002-6","volume":"56","author":"Fern\u00e1ndez J.","year":"2012","unstructured":"Fern\u00e1ndez J, Gustot T. Management of bacterial infections in cirrhosis.","journal-title":"J Hepatol"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4254\/wjh.v8.i6.307","volume":"8","author":"Bunchorntavakul C.","year":"2016","unstructured":"Bunchorntavakul C, Chamroonkul N, Chavalitdhamrong D. Bacterial infections in cirrhosis: A critical review and practical guidance.","journal-title":"World J Hepatol"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.4254\/wjh.v9.i30.1166","volume":"9","author":"Fiore M.","year":"2017","unstructured":"Fiore M, Maraolo AE, Gentile I. Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis.","journal-title":"World J Hepatol"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1469-0691.2010.03425.x","volume":"17","author":"Paul M.","year":"2011","unstructured":"Paul M, Zemer-Wassercug N, Talker O. Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?","journal-title":"Clin Microbiol Infect"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.3748\/wjg.v23.i25.4654","volume":"23","author":"Fiore M.","year":"2017","unstructured":"Fiore M, Maraolo AE, Gentile I. Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic review.","journal-title":"World J Gastroenterol"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MEG.0000000000001057","volume":"30","author":"Fiore M.","year":"2018","unstructured":"Fiore M, Gentile I, Maraolo AE. Are third-generation cephalosporins still the empirical antibiotic treatment of community acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"pii 30399","DOI":"10.2807\/1560-7917.ES.2016.21.46.30399","volume":"21","author":"Weist K.","year":"2016","unstructured":"Weist K, H\u00f6gberg LD. ECDC publishes 2015 surveillance data on antimicrobial resistance and antimicrobial consumption in Europe.","journal-title":"Euro Surveill"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.pop.2018.05.006","volume":"45","author":"Morehead M.S.","year":"2018","unstructured":"Morehead MS, Scarbrough C. Emergence of Global Antibiotic Resistance.","journal-title":"Prim Care"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/hep.28476","volume":"63","author":"Ison M.G.","year":"2016","unstructured":"Ison MG. Empiric treatment of nosocomial spontaneous bacterial peritonitis: one size does not fit all.","journal-title":"Hepatology"},{"key":"ref=71","first-page":"224","volume":"25","author":"Viceconte G.","year":"2017","unstructured":"Viceconte G, Maraolo AE, Iula VD, Catania MR, Tosone G, Orlando R. Appropriateness of antibiotic prescription for targeted therapy of infections caused by multidrug-resistant bacteria: assessment of the most common improper uses in a tertiary hospital in southern Italy.","journal-title":"Infez Med"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijantimicag.2018.05.010","volume":"52","author":"Menichetti F.","year":"2018","unstructured":"Menichetti F, Falcone M, Lopalco P. The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy.","journal-title":"Int J Antimicrob Agents"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/hep.27941","volume":"63","author":"Piano S.","year":"2016","unstructured":"Piano S, Fasolato S, Salinas F. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial.","journal-title":"Hepatology"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/liv.13457","volume":"37","author":"Maraolo A.E.","year":"2017","unstructured":"Maraolo AE, Giacobbe DR, Fiore M. The diagnostic conundrum of bacterial infections in cirrhotic patients.","journal-title":"Liver Int"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2015.10.019","volume":"64","author":"Nadim M.K.","year":"2016","unstructured":"Nadim MK, Durand F, Kellum JA. Management of the critically ill patient with cirrhosis: A multidisciplinary perspective.","journal-title":"J Hepatol"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/hep.25931","volume":"56","author":"Arabi Y.M.","year":"2012","unstructured":"Arabi YM, Dara SI, Memish Z. Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis.","journal-title":"Hepatology"},{"key":"ref=77","first-page":"1156","volume":"81","author":"Carey W.","year":"1986","unstructured":"Carey W, Boayke A, Leatherman J. Spontaneous bacterial peritonitis, clinical and laboratory features with reference to hospital acquired cases.","journal-title":"Am J Gastroenterol"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1741-7015-12-40","volume":"12","author":"Cardoso T.","year":"2014","unstructured":"Cardoso T, Almeida M, Friedman ND. Classification of healthcare-associated infection: A systematic review 10 years after the first proposal.","journal-title":"BMC Med"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/QCO.0b013e3282f4f248","volume":"21","author":"Carratal\u00e0 J.","year":"2008","unstructured":"Carratal\u00e0 J, Garcia-Vidal C. What is healthcare-associated pneumonia and how is it managed?","journal-title":"Curr Opin Infect Dis"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"Kalil A.C.","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.","journal-title":"Clin Infect Dis"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/MCP.0000000000000367","volume":"23","author":"Metersky M.L.","year":"2017","unstructured":"Metersky ML, Kalil AC. New guidelines for nosocomial pneumonia.","journal-title":"Curr Opin Pulm Med"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cgh.2012.10.040","volume":"11","author":"Mellinger J.L.","year":"2013","unstructured":"Mellinger JL, Volk ML. Multidisciplinary management of patients with cirrhosis: A need for care coordination.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127448","volume":"10","author":"Merli M.","year":"2015","unstructured":"Merli M, Lucidi C, Di Gregorio V. The spread of multi-drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: A prospective survey.","journal-title":"PLoS One"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/eci.12701","volume":"47","author":"Lutz P.","year":"2017","unstructured":"Lutz P, Nischalke HD, Kr\u00e4mer B. Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis.","journal-title":"Eur J Clin Invest"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.28332","volume":"63","author":"Merli M.","year":"2016","unstructured":"Merli M, Lucidi C, Di Gregorio V. An empirical broad spectrum antibiotic therapy in health-care-associated infections improves survival in patients with cirrhosis: A randomized trial.","journal-title":"Hepatology"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.23736\/S0375-9393.17.12034-1","volume":"83","author":"Fiore M.","year":"2017","unstructured":"Fiore M, Chiodini P, Pota V. Risk of spontaneous fungal peritonitis in hospitalized cirrhotic patients with ascites: A systematic review of observational studies and meta-analysis.","journal-title":"Minerva Anestesiol"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ajg.2017.471","volume":"113","author":"Bajaj J.S.","year":"2018","unstructured":"Bajaj JS, Rajender Reddy K, Tandon P. Prediction of fungal infection development and their impact on survival using the NACSELD cohort.","journal-title":"Am J Gastroenterol"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jhep.2015.05.032","volume":"63","author":"Alexopoulou A.","year":"2015","unstructured":"Alexopoulou A, Vasilieva L, Agiasotelli D, Dourakis SP. Fungal infections in patients with cirrhosis.","journal-title":"J Hepatol"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jhep.2016.01.039","volume":"64","author":"Bucsics T.","year":"2016","unstructured":"Bucsics T, Schwabl P, Mandorfer M, Peck-Radosavljevic M. Prognosis of cirrhotic patients with fungiascites and spontaneous fungal peritonitis (SFP).","journal-title":"J Hepatol"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1046\/j.1440-1746.1999.01996.x","volume":"14","author":"Yang C.","year":"1999","unstructured":"Yang C, Yeh CT, Hung CF, Liaw YF. Case report: spontaneous peritonitis caused by","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00004836-200104000-00020","volume":"32","author":"Nair S.","year":"2001","unstructured":"Nair S, Kumar KS, Sachan P, Corpuz M. Spontaneous fungal peritonitis (Candida glabrata) in a patient with cirrhosis.","journal-title":"J Clin Gastroenterol"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4254\/wjh.v10.i2.254","volume":"10","author":"Shizuma T.","year":"2018","unstructured":"Shizuma T. Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review.","journal-title":"World J Hepatol"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10096-013-1953-2","volume":"33","author":"Hwang S.Y.","year":"2014","unstructured":"Hwang SY, Yu SJ, Lee JH. Spontaneous fungal peritonitis: A severe complication in patients with advanced liver cirrhosis.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/myc.12321","volume":"58","author":"Bremmer D.N.","year":"2015","unstructured":"Bremmer DN, Garavaglia JM, Shields RK. Spontaneous fungal peritonitis: A devastating complication of cirrhosis.","journal-title":"Mycoses"},{"key":"ref=95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158389","volume":"11","author":"Lahmer T.","year":"2016","unstructured":"Lahmer T, Brandl A, Rasch S, Schmid RM, Huber W. Fungal peritonitis: Underestimated disease in critically ill patients with liver cirrhosis and spontaneous peritonitis.","journal-title":"PLoS One"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/MEG.0000000000000927","volume":"29","author":"Gravito-Soares M.","year":"2017","unstructured":"Gravito-Soares M, Gravito-Soares E, Lopes S, Ribeiro G, Figueiredo P. Spontaneous fungal peritonitis: A rare but severe complication of liver cirrhosis.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.28443","volume":"64","author":"Piano S.","year":"2016","unstructured":"Piano S, Angeli P. Reply to Preemptive therapy of spontaneous fungal peritonitis.","journal-title":"Hepatology"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00134-017-4717-0","volume":"43","author":"Bassetti M.","year":"2017","unstructured":"Bassetti M, Peghin M, Carnelutti A. Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: A multicenter study.","journal-title":"Intensive Care Med"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1017\/ice.2018.33","volume":"39","author":"Manning M.L.","year":"2018","unstructured":"Manning ML, Septimus EJ, Ashley ESD. Antimicrobial stewardship and infection prevention-leveraging the synergy: a position paper update.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/14787210.2016.1233060","volume":"14","author":"Gentile I.","year":"2016","unstructured":"Gentile I, Maraolo AE, Borgia G. What is the role of the new \u03b2-lactam\/\u03b2-lactamase inhibitors ceftolozane\/tazobactam and ceftazidime\/avibactam?","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamasurg.2016.4237","volume":"152","author":"Solomkin J.","year":"2017","unstructured":"Solomkin J, Evans D, Slepavicius A. Assessing the efficacy and safety of eravacycline ertapenem in complicated intra-abdominal infections in the investigating gram-negative infections treated with eravacycline (IGNITE 1) trial: A randomized clinical trial.","journal-title":"JAMA Surg"}],"container-title":["Reviews on Recent Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/168008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T14:09:28Z","timestamp":1662559768000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/168008\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,31]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5,31]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574887114666181204102516","relation":{},"ISSN":["1574-8871"],"issn-type":[{"value":"1574-8871","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,31]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-09-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}